ArticleEJIFCC2016
Progress in Metabolomics Standardisation and its Significance in Future Clinical Laboratory Medicine.
Article in EJIFCC, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Emerging Quantitative Targeted Metabolomics Approaches for Future Inborn Errors of Metabolism Screening.Diagnostics (Basel, Switzerland) · 2026Review
- STRIKER: a spectral metadata repairing tool for expanding the comprehensiveness of spectral libraries.Journal of cheminformatics · 2026Article
- Intelligent Discrimination of Grain Aging Using Volatile Organic Compound Fingerprints and Machine Learning: A Comprehensive Review.Foods (Basel, Switzerland) · 2026Review
- Exposure to oral contraceptives alters human endometrial stem cells culture media secretome.JBRA assisted reproduction · 2026Article
- Unlocking Plant Resilience: Metabolomic Insights into Abiotic Stress Tolerance in Crops.Metabolites · 2025Review
- From Biomarker Discovery to Clinical Applications of Metabolomics in Glioblastoma.Metabolites · 2025Review
- An evaluation of untargeted metabolomics methods to characterize inborn errors of metabolism.Molecular genetics and metabolism · 2024Review
- Metabolomics: An Emerging "Omics" Platform for Systems Biology and Its Implications for Huntington Disease Research.Metabolites · 2023Review
- Technical Report: A Comprehensive Comparison between Different Quantification Versions of Nightingale Health'sMetabolites · 2023Article
- Correlations for untargeted GC × GC-HRTOF-MS metabolomics of colorectal cancer.Metabolomics : Official journal of the Metabolomic Society · 2023Article
- Keep It Simple: Using README Files to Advance Standardization in Chronobiology.Clocks & sleep · 2023Article
- SMetaS: A Sample Metadata Standardizer for Metabolomics.Metabolites · 2023Article
- Diagnostic, Prognostic and Mechanistic Biomarkers of COVID-19 Identified by Mass Spectrometric Metabolomics.Metabolites · 2023Review
- Evidence for ethnicity and location as regulators of the newborn blood metabolome: a monozygous twin study.Frontiers in nutrition · 2023Article
- Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC).Metabolomics : Official journal of the Metabolomic Society · 2022Review
- Review
- Comparative metabolomics analysis of bronchial epithelium during barrier establishment after allergen exposure.Clinical and translational allergy · 2021Article
- Metabolic Signature of Arrhythmogenic Cardiomyopathy.Metabolites · 2021Article
- LC-MS untargeted metabolomics assesses the delayed response of glufosinate treatment of transgenic glufosinate resistant (GR) buffalo grasses (Stenotaphrum secundatum L.).Metabolomics : Official journal of the Metabolomic Society · 2021Article
- Predicting human health from biofluid-based metabolomics using machine learning.Scientific reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Today, the technology of 'targeted' based metabolomics is pivotal in the clinical analysis workflow as it provides information of metabolic phenotyping (metabotypes) by enhancing our understanding of metabolism of complex diseases, biomarker discovery for disease development, progression, treatment, and drug function and assessment. This review is focused on surveying and providing a gap analysis on metabolic phenotyping with a focus on targeted based metabolomics from an instrumental, technical
Indexed as
Identifiers
28149265PMC5282916What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.